ATC code H03: Difference between revisions

ATC codes
H Systemic hormonal preparations, excluding sex hormones and insulins
	H01 Pituitary and hypothalamic hormones and analogues
	H02 Corticosteroids for systemic use
	H03 Thyroid therapy
	H04 Pancreatic hormones
	H05 Calcium homeostasis
A B C D G H QI J L M N P R S V ; (Hover over links to see titles) ;

Revision as of 05:35, 10 February 2025

ATC code H03 Thyroid therapy is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.<ref>

ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis(link). {{{website}}}. National Institutes of Health.

</ref><ref>

ATC-Klassifikation mit definierten Tagesdosen DDD(link). {{{website}}}. German Institute for Medical Documentation and Information.

ATC/DDD Index 2022

code H03(link).

{{{website}}}. WHO Collaborating Centre for Drug Statistics Methodology.

</ref>

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QH03.<ref>

ATCvet Index 2022

code QH03(link).

{{{website}}}. WHO Collaborating Centre for Drug Statistics Methodology.

</ref>

National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

H03AA03 Combinations of levothyroxine and liothyronine

H03BB52 Thiamazole, combinations

Revision as of 18:31, 10 September 2019 edit Prab (talk \| contribs) , Bureaucrats, Interface administrators, Administrators 1,432,208 edits m 1 revision imported		Revision as of 05:35, 10 February 2025 edit undo Prab (talk \| contribs) , Bureaucrats, Interface administrators, Administrators 1,432,208 edits CSV import Newer edit →
Line 39:		Line 39:

	[[Category:ATC codes\|H03]]		[[Category:ATC codes\|H03]]
			{{No image}}